Example heatmaps show cluster phenotypes (expression profiles) and differential signal of interest (relative cluster abundances or expression of signaling marker pS6, by sample), with annotation for detected significant clusters or cluster-marker combinations (red) and true differential clusters or cluster-marker combinations (black). A detailed description of the diffcyt methodology is provided in Methods.
Method
Short description Limitations Ref.
Citrus
Uses hierarchical clustering and regularized regression or classification models to select predictive features, such as cluster abundances or median expression of functional markers, that are associated with an outcome of interest.
• Detected features cannot be ranked by importance.
• Lasso-regularized models cannot easily detect multiple correlated features.
• Rare cell populations cannot easily be detected, due to minimum cluster size requirement and computational limitations.
• Response variable is the clinical outcome variable, which makes it difficult to account for complex experimental designs (including batch effects, paired designs, and continuous covariates).
[9]
CellCnn Applies convolutional neural networks in a representation learning framework to detect rare cell populations associated with an outcome of interest. Designed specifically for detecting rare cell populations.
• Ranking of detected cells cannot be interpreted in terms of statistical significance.
• Interpretation of detected populations (referred to as filters) can be difficult, since they may be composed of multiple distinct cell populations.
• All protein markers are treated identically;
there is no conceptual split between cell type and cell state (or functional) markers.
[10]
cydar Assigns cells to overlapping hyperspheres in the highdimensional space; tests for differential abundance between hyperspheres using moderated tests from edgeR [15, 16] , while controlling the spatial false discovery rate among overlapping hyperspheres.
• Rare cell populations cannot easily be detected, due to their relatively small volume in the high-dimensional space.
• All protein markers are treated identically; there is no conceptual split between cell type and cell state (or functional) markers.
[11]
classic regressionbased approach Automated clustering using FlowSOM [14], followed by manual merging and annotation to define cell populations; differential testing of features such as population abundances or median expression of functional markers using generalized linear mixed models, linear mixed models, or linear models.
• Manual merging and annotation step requires expert biological knowledge, and can be time-consuming and subjective.
• When testing large numbers of clusters, e.g. to detect rare cell populations: loss of statistical power due to multiple testing penalty; no sharing of information across clusters.
[12] 
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for one subtype (CN) and one threshold (1%), for all diffcyt DA methods as well as Citrus,
99
CellCnn, and cydar (complete results are included in Supplementary Figure 1 an optimum is observed across a broad range, including 100 clusters.
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Successful recovery of known signals in experimental data
171
In order to demonstrate our methods on experimental data, we re-analyzed a dataset from a 172 recent study using mass cytometry to characterize immune cell subsets in peripheral blood CD11c  CD123  CD14  CD141  CD16  CD19  CD1c  CD209  CD274_PDL1  CD3  CD303  CD33  CD34  CD38  CD56  CD61  CD62L  CD64  CD66b  CD7  CD86  HLA−DR  ICAM−1   samples   NR1  NR2  NR3  NR4  NR5  NR6  NR7  NR8  NR9  R1  R2  R3  R4  R5  R6  R7  R8  R9  R10 Figures 2-3) ; we recommend these as the default choices.
HLA-DR
hi ICAM-1 + CD64 + CD141 + CD86 + CD11c + CD38 + PD-L1 + CD11b + monocytes)
221
One limitation of our framework is that groups of similar clusters cannot be automatically tests, and affects power through the multiple testing penalty and the counts per cluster.
263
We recommend higher numbers of clusters when rare cell populations are of interest (for 264 example, we used 400 clusters for the AML-sim dataset, and 100 clusters for the BCR-XL-sim 265 dataset). Ultimately, this is a subjective choice for the user, which may also be explored 
273
In general, we note that our methods are designed for 'discovery' analyses: all results
274
should be explored and interpreted using visualizations, and any generated hypotheses The following sections provide a detailed description of the diffcyt methodology (see Figure 1 286 for a schematic overview). interpret the results in terms of cell populations defined by known cell type markers.
301
The grouping into cell type and cell state markers must be specified by the user, and 
